About
Giles Platford is president of Takeda's International Business Unit, overseeing markets outside the U.S. He joined Takeda in 2009 as general manager of Brazil and held subsequent roles including area head for Middle East, Turkey & Africa, president of Emerging Markets, president of Europe & Canada, and president of the Plasma-Derived Therapies Business Unit. Before Takeda he spent eight years in Asia Pacific in business development, commercial, and general management roles, and holds a business and marketing management degree from Oxford Brookes University.
Experience
- TakedaPresident, Internationalcurrent2026 — presentTokyo, Japan
- TakedaPresident, Plasma-Derived Therapies2022 — 2026Cambridge, Massachusetts, United States
- TakedaPresident, Europe & Canada2017 — 2022Zurich, Switzerland
- TakedaPresident, Emerging Markets2014 — 2017Singapore
- TakedaArea Head, Middle East, Turkey & Africa2013 — 2014Dubai
- TakedaGeneral Manager, Brazil2011 — 2013Sao Paulo, Brazil
- Healthcare Businesswomen’s AssociationBoard Membercurrent2025 — present
- Community ServingsBoard Member2025 — 2026
- Plasma Protein Therapeutics Association (PPTA)Board Chair2022 — 2026
- EFPIA - European Federation of Pharmaceutical Industries and AssociationsBoard Member & Chair of the Innovation Committee2017 — 2022Brussels Area, Belgium
- NycomedEVP - Commercial Operations, Brazil2009 — 2010Sao Paulo, Brazil
- Invida Pharmaceutical Holdings Pte.Country Manager, Malaysia & Singapore2007 — 2009Greater Kuala Lumpur
- Invida Pharmaceutical Holdings Pte.Regional Commercial Manager, Asia Pacific2006 — 2007Singapore
- Invida Pharmaceutical Holdings Pte.Commercial Manager, China2004 — 2006Shanghai, China
- Zuellig PharmaBusiness Development Manager2003 — 2004Manila, Philippines
- Zuellig PharmaBusiness Development APAC2002 — 2003Bangkok, Thailand
- Zuellig PharmaProject Lead2001 — 2002Hong Kong SAR
- PwCManagement Consultant1999 — 2000Sydney, New South Wales, Australia
Shared employers
Also worked at Healthcare Businesswomen’s Association2
Also worked at Plasma Protein Therapeutics Association (PPTA)1
Also worked at Zuellig Pharma2
Colleagues at Takeda Ventures
Akiko Amakawa
CEO Chief of Staff at Takeda Ventures
Andrew S. Plump
Director - President, Research & Development at Takeda Ventures
Asuka Miyabashira
President, Japan Pharma Business Unit at Takeda Ventures
Awny Farajallah
Chief Medical Officer at Takeda Ventures
Christophe Weber
President and CEO, Representative Director at Takeda Ventures
Elaine Shannon
President, Global Supply & Quality at Takeda Ventures
Gabriele Ricci
Chief Data & Technology Officer at Takeda Ventures
Jasmina Marjanovic
Partner at Takeda Ventures









